| Literature DB >> 30170173 |
Damian Kloska1, Aleksandra Kopacz1, Aleksandra Piechota-Polanczyk1, Witold N Nowak1, Jozef Dulak1, Alicja Jozkowicz1, Anna Grochot-Przeczek2.
Abstract
Aging is the most critical risk factor for the development of cardiovascular diseases and their complications. Therefore, the fine-tuning of cellular response to getting older is an essential target for prospective therapies in cardiovascular medicine. One of the most promising targets might be the transcription factor Nrf2, which drives the expression of cytoprotective and antioxidative genes. Importantly, Nrf2 expression correlates with potential lifespan in rodents. However, the effect of Nrf2 activity in vascular diseases might be ambiguous and strongly depend on the cell type. On the one hand, the Nrf2 activity may protect cells from oxidative stress and senescence, on the other hand, total lack of Nrf2 is protective against atherosclerosis development. Therefore, this review aims to discuss the current knowledge on the role played by the transcription factor Nrf2 in cardiovascular diseases and its potential effects on aging.Entities:
Keywords: Aging; Cardiovascular diseases; Endothelial cells; Nrf2; Senescence; Vascular system
Mesh：
Substances：
Year: 2018 PMID： 30170173 DOI： 10.1016/j.vph.2018.08.009
Source DB: PubMed Journal: Vascul Pharmacol ISSN： 1537-1891 Impact factor: 5.773